Sublime contains phospholipids, choline, omega-3 PUFAs, and astaxanthin.
Photo © iStockphoto.com/ Tenedos
The Rimfrost joint venture between Olympic Seafood and Avoca Inc. made a splash when it announced itself as the newest krill oil supplier back in 2012. Rimfrost is now extending beyond just DHA and EPA omega-3 polyunsaturated fatty acids (PUFAs) and emphasizing the other beneficial ingredients in krill oil-namely, its high phospholipid content and the natural antioxidant astaxanthin. The company says it will introduce an ultra-high-phospholipid extract from krill oil, called Sublime, at next week’s SupplySide West show.
Sublime contains phospholipids, choline, omega-3 PUFAs, and astaxanthin. “Phospholipids are carriers and storage units for choline and PUFAs,” the company explains. Sublime is said to have a high phospholipid content-up to 60%, it says-and its nutrients can ably cross the blood-brain barrier.
Rimfrost describes itself as “reframing” its market and “positioning itself outside of the omega-3 category.”
“For a long time, we have talked about krill as the next-generation omega-3,” said sales and marketing director John Cameron, in a press release. “Our experience and the advice of our customers has confirmed that while the omega-3 component is still important, there is much more to krill…”
DHA and EPA PUFAs are still “prominent” in the new ingredient, but Rimfrost is also highlighting Sublime’s choline content, which can leverage authorized health claims in the EU and nutrient content claims in the United States. The company points to growing interest in choline’s role in several body systems, including the management of homocystein metabolism, which has been linked to numerous health disorders.
Also read:
Why Krill Oil Is More Stable than Fish Oil
DSM Says It Has New Data on the Krill versus Fish Oil Bioavailability Debate-They’re Similar
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.